Clinical significance of sarcopenia in children with neuroblastic tumors
Pediatric Surgery International · 2024
DOI: 10.1007/s00383-024-05815-9 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pediatric Surgery International, 2024. Verfasst von Wataru Kudo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan. ccfa4833@chiba-u.jp. Hauptthemen laut MEDLINE: Neuroblastoma, Sarcopenia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Purpose
To elucidate the clinical significance of sarcopenia in children with neuroblastic tumors (NTs).
Methods
We conducted a retrospective observational study and analyzed the z-scores for height, body weight, body mass index, and skeletal muscle index (HT-z, BW-z, BMI-z, and SMI-z) along with the clinical characteristics of 36 children with NTs. SMI-z was calculated from 138 computed tomography scans at diagnosis, during treatment, and at follow-up. The International Neuroblastoma Risk Group classification was used to identify high-risk groups. We analyzed the data at diagnosis for prognostic analysis and changes over time after diagnosis in the HT-z, BW-z, BMI-z, and SMI-z groups.
Results
Among the four parameters at diagnosis, only SMI-z predicted overall survival (hazard ratio, 0.58; 95% confidence interval, 0.34–0.99). SMI-z, HT-z, and BW-z significantly decreased over time after diagnosis ( P < 0.05), while BMI-z did not ( P = 0.11). In surviving high-risk NT cases without disease, SMI-z, HT-z, and BW-z significantly decreased over time ( P < 0.05), while BMI-z did not ( P = 0.43).
Conclusion
In children with NT, the SMI-z at diagnosis was a significant prognostic factor and decreased during treatment and follow-up along with HT-z and BW-z. Monitoring muscle mass is important because sarcopenia may be associated with growth impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan. ccfa4833@chiba-u.jp.
- Division of Pediatric Surgery, Department of Surgery, Graduate School of Medicine, Jichi Medical University, Shimotsuke, Japan.
- Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.
Zitieren
APA
Kudo, W., Terui, K., Furugane, R., Takenouchi, A., Komatsu, S., Kawaguchi, Y., Nishimura, K., Katsumi, D., & Hishiki, T. (2024). Clinical significance of sarcopenia in children with neuroblastic tumors. Pediatric Surgery International. https://doi.org/10.1007/s00383-024-05815-9
Vancouver
Kudo W, Terui K, Furugane R, Takenouchi A, Komatsu S, Kawaguchi Y, et al. Clinical significance of sarcopenia in children with neuroblastic tumors. Pediatric Surgery International. 2024. doi:10.1007/s00383-024-05815-9
BibTeX
@article{Kudo2024,
author = {Kudo, Wataru and Terui, Keita and Furugane, Ryoya and Takenouchi, Ayako and Komatsu, Shugo and Kawaguchi, Yunosuke and Nishimura, Katsuhiro and Katsumi, Daisuke and Hishiki, Tomoro},
title = {Clinical significance of sarcopenia in children with neuroblastic tumors},
journal = {Pediatric Surgery International},
year = {2024},
doi = {10.1007/s00383-024-05815-9}
}
EUVIMED